Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting
WARSAW, Ind., Feb. 12, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is showcasing the latest innovations across its product portfolio at the 2024 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) this week in San Francisco. During the meeting, the company will display its forthcoming ROSA® Robotics application for shoulder replacement,* which is pending 510(k) clearance, and provide hands-on demonstrations of key growth drivers including Persona® OsseoTi® Keel Tibia for cementless knee replacement, ROSA® Robotics (ROSA Knee and ROSA Hip), Ambulatory Surgery Center (ASC) Solutions, as well as recently launched surgical tools including HAMMR™ Automatic Hip Impaction System, and the ViVi® Surgical Helmet System.
- "Every year, the annual AAOS meeting gives us an opportunity to not only demonstrate the breadth and diversity of our portfolio, but also shine a spotlight on the bold and meaningful innovations that transform clinical care, improve the surgical experience, and give us a differentiated competitive advantage," said Mark Bezjak, President of the Americas at Zimmer Biomet.
- ZBEdge™ Dynamic Intelligence™ : Elevates and unlocks the full potential of Zimmer Biomet's cutting-edge digital, robotic and implant solutions.
- In addition, the company will provide updates on its ASC strategy, partnerships and comprehensive portfolio.
- For more information about Zimmer Biomet events at AAOS 2024, visit http://www.zimmerbiomet.com/academy2024 .